• Clinical Outcome Study

    Clinical Outcome Study

    An opportunity to participate in a clinical research study that is essential for defining outcome measures for clinical trials by measuring how these conditions develop and progress. Without good clinical outcomes, effective clinical trials cannot be performed.
    Read more

  • About the Disease

    About the Disease

    LGMD2B/Miyoshi Myopathy (collectively called dysferlinopathy) are rare forms of muscular dystrophy caused by mutations in the dysferlin gene. For the disease to occur both copies of the dysferlin gene must be defective (recessive inheritance).
    Read more

  • Importance of Genetic Diagnosis

    Importance of Genetic Diagnosis

    Since multiple forms of muscular dystrophy can have similar clinical symptoms, genetic analysis is the only definitive way to confirm your diagnosis of LGMD2B / Miyoshi. The Jain Foundation can help you obtain this genetic analysis.
    Read more

Patient StoryPatient Story

Patient Story

Lary

I was always an active, athletic kid, who loved playing baseball, football, basketball, tennis, and golf. At approximately 13 or 14 years old, I noticed that I could not run as fast as I did in the past.
Read more...

News and Update

The Jain Foundation is happy to share a recent article from Stanford showcasing Tom Rando’s fantastic leadership and Katie Maguire’s work to develop an exciting new mouse model.

  1. 06.17.2013 Message from the President more
  2. 06.17.2013 President's Letter (2010 Conference) more
  3. 06.14.2013 Quantification of lipid in dysferlin-deficient muscles and other dystrophies more
  4. 06.14.2013 Investigation of pre-pathological aetiology of dysferlinopathy in the mouse more